Skip to main content Skip to navigation

Supporting Trials


We work in partnership with a range of organisations on large scale multi-centre clinical trials. Discover some of the projects we're currently collaborating on.

Supporting trials

Trial name Description Collaborator Status
AVAST-M A trial looking at bevacizumab after surgery for melanoma skin cancer

Cancer Research UK Results
COPERS Can we identify how programmes aimed at promoting self management in musculoskeletal pain work and who benefits? A systematic review of sub-group analysis within RCTs. Barts and the London School of Medicine and Dentistry Writing up results
COUGAR-2 A trial looking at docetaxel chemotherapy for advanced cancer of the stomach, the oesophagus or the junction of the stomach and oesophagus Cancer Research UK Results
LIHNCS A trial looking at using a dye during surgery for mouth and throat cancer. Cancer Research UK


LIPOS Liraglutide in PCOS (LIPOS) Study: Evaluation of the Efficacy of Liraglutide on Menstrual Cyclicity in Women with PCOS - a prospective randomised double-blind placebo-controlled study Reproductive health Closed
Neo-escape A trial looking at chemotherapy before and after surgery for advanced peritoneal cancer

Cancer Research UK Results
Neo-tAnGo A trial looking at chemotherapy before surgery for breast cancer Cancer Research UK Results
OSCAR The trial is comparing conventional positive pressure ventilationwith high frequency oscillatory ventilation (HFOV) for adults with acute respiratory distress syndrome. University of Oxford Completed
PG-SNPS A study looking at why people respond differently to the same chemotherapy Cancer Research UK Closed

Investigating whether a cognitive behavioural approach (CBA) intervention, delivered prior to PR can help to improve mild to moderate anxiety and/or depression in those with moderate to very severe COPD and consequently encourage PR uptake/completion.

Queen Mary University of London Follow-up
VICTOR The trial’s aim was to answer the question of whether VIOXX®, a potent orally active COX-2 inhibitor licensed for use in osteoarthritis, has a role as maintenance therapy in colorectal cancer patients following potentially curative therapy. University of Oxford Completed
WHITE Exploring a research framework that can provide meaningful data regarding the clinical and cost effectiveness of treatments of fracture of the proximal femur University of Oxford Recruiting